ARCHIVES

Caution Advised for Hormone Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Knudson To Head Fox Chase Center

November 21, 1980

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993